For World AIDS Day, Curtis Chan from the Kirby Institute talks through the findings of the PrEP Appeal Study. The research found that cost and access are the main barriers to more people using pre-exposure prophylaxis, or PrEP.
Australia is getting close to eliminating HIV transmission, but inequities in the delivery and uptake of prevention and treatment strategies remain.
An international clinical trial has explored alternative approaches to second-line HIV therapy - with promising results.
Forty years after the first case of AIDS was described in the United States, the number of people diagnosed with HIV in Australia is at an all-time low.
We don’t know enough about biological processes in people who are ageing with HIV - a new study sheds light on the matter.
Last week, thousands tuned in online to hear guest speaker Dr Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases at the US National Institutes of Health.
New HIV data, released today by the Kirby Institute at UNSW Sydney for World AIDS Day, are a reminder for Australia to sustain its efforts in HIV prevention amidst the COVID-19 pandemic.
A global-first, UNSW-led trial of an HIV prevention medication has resulted in an almost one-third decline in infections in the large-scale target group.
An increase in condomless sex in pre-exposure prophylaxis users is predictable as preventing HIV is the key motivator for condom use among gay and bisexual men.
Infectious diseases expert Clifford Lane will deliver UNSW Medicine's Dean's Lecture, outlining the challenges ahead to find a cure for the close to 40 million people living with HIV/AIDS.